Abhishek Kognole, PhD

Scientific & Business Development Manager

Dr. Kognole brings molecular modeling, enhanced sampling, and forcefield development experience to the SilcsBio team. He is passionate about integrating computational approaches with experiments for faster and better drug design.

Steven Gossert, PhD

Applications Scientist, Computational Drug Design

Dr. Gossert brings expertise in modeling workflows for biologics and small-molecule formulations to the SilcsBio team. He is passionate about using predictive computational tools to streamline drug-product development and expand the impact of SILCS-based methods in pharmaceutical science.

Ashlin Poruthoor, PhD

Applications Scientist

Dr. Poruthoor has expertise in molecular dynamics, molecular modeling, cheminformatics, and
machine learning-based property prediction. His focus is on bridging physics-based molecular insights with data-driven models to streamline our partners’ drug discovery efforts.

Alexander MacKerell, PhD

Chief Science Officer

Dr. MacKerell is a co-inventor of SilcsBio’s core technology and brings a deep understanding of the computational drug design market and technologies, He is the Grollman-Glick Professor of Pharmaceutical Sciences and Director of the Computer-Aided Design Center at the University of Maryland.

Olgun Guvench, PhD

Managing Partner

Dr. Guvench is co-inventor of SilcsBio’s core technology and brings extensive expertise in force field-based molecular dynamics simulations. He is a professor in the Department of Pharmaceutical Sciences and Administration at the University of New England.

Kelsey Abernathy, PhD

Chief Executive Officer

Dr. Abernathy brings expertise as a PhD biologist and seasoned entrepreneur. She has more than a decade of experience leading teams of scientists and business operators and has helped commercialize more than a dozen products. She understands how to translate novel technologies from research labs to commercial markets while prioritizing the needs of customers across various industries.